✦ LIBER ✦

P108 INFLIXIMAB DISCONTINUATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

✍ Scribed by F. Bermejo; A. López-San Román; A. Algaba; M. Van Domselaar; J.A. Carneros; E. Garrido; B. Piqueras; M.P. Valer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P256 Outcome after discontinuation of in

✍ A. Molazahi; C. Steenholdt; M. Ainsworth; J. Brynskov; O. Thomsen; J. Seidelin 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 154 KB

P275 Evaluation of the discontinuation o

✍ Z. Zelinkova; C. Van der Ent; K. Bruin; O. Van Baalen; H. Vermeulen; H. Smalbraa 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 53 KB

Serious Events with Infliximab in Patien

✍ Hilbert S. de Vries, Martijn G. H. van Oijen, Dr Dirk J. de Jong 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 116 KB

1124 Long Term Prognosis After Discontin

✍ Casper Steenholdt; Akbar Molazahi; Mark A. Ainsworth; Jorn Brynskov; Ole Thomsen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 163 KB

P108 Towards patient-reported disease se

✍ Alrubaiy, L.; Williams, J.; Hutchings, H. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 54 KB

P.62 INFLIXIMAB MODULATES MUCOSAL CYTOKI

✍ F. Caprioli; F. Bosè; L. Raeli; C. Viganò; G. Basilisco; D. Conte; S. Abrignani; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB